Leukemia
📧 Sign up to get email alerts when something new happens for Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder [Phase 2]
Phase 2 trial evaluating arsenic trioxide, ascorbic acid, dexamethasone, and thalidomide in chronic myeloproliferative disorders, leukemia, …
-
CLINICAL_TRIALS trial_result · 2020-07-27Clinical Trial Update: Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial [Phase 3]
Phase 3 clinical trial update focusing on personalized or basic information to aid decision-making for participating in a trial.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy [Phase 2]
Phase 2 trial update on allogeneic bone marrow transplantation with less intensive therapy; the study was terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2020-05-05Clinical Trial Update: Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT) [Phase 2]
Phase 2 clinical trial update on Zevalin-containing nonmyeloablative conditioning for stem cell transplantation in leukemia and lymphoma; re…
-
CLINICAL_TRIALS trial_result · 2020-04-24Clinical Trial Update: A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status [Phase 1]
Phase I study of AC220 (trastuz? actually AC220 is quizartinib, a FLT3 inhibitor) in relapsed/refractory AML regardless of FLT3 status; comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies [Phase 2]
Phase 2 trial evaluating Thiotepa-Clofarabine-Busulfan conditioning with allogeneic stem cell transplant for high-risk malignancies has comp…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Treatment for Chronic Pain in Patients With Advanced Cancer [Phase 3]
Phase 3 clinical trial update for a treatment addressing chronic pain in patients with advanced cancer; status indicates completed.
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation [Phase 2]
Phase 2 trial evaluating autologous CMV-specific cytotoxic T cells for CMV reactivation in leukemia and lymphoma patients has completed with…
-
CLINICAL_TRIALS trial_result · 2020-03-10Clinical Trial Update: Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant [Phase 2]
Phase 2 clinical trial evaluating chemotherapy plus donor lymphocyte infusion to prevent second relapse after allogeneic stem cell transplan…
-
CLINICAL_TRIALS trial_result · 2020-02-24Clinical Trial Update: Pilot Study to Determine Effects of the Btk Inhibitor PCI-32765 on Leukemia Cell Kinetics and Trafficking, Using Heavy Water Labeling in Subjects With CLL and SLL [Phase 1, Phase 2]
A pilot study evaluating the Btk inhibitor PCI-32765 (ibrutinib) effects on leukemia cell kinetics and trafficking in CLL/SLL using heavy wa…
-
CLINICAL_TRIALS trial_result · 2020-02-18Clinical Trial Update: Eltrombopag With or Without Hypomethylating Agent After Hypomethylating Agent Failure For Patients With Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 clinical trial evaluating eltrombopag with or without a hypomethylating agent after hypomethylating agent failure in patients with m…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders [Phase 2]
Phase 2 trial update of an allogeneic hematopoietic cell transplant in hematologic cancers/disorders; status completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2020-01-31Clinical Trial Update: Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 [Phase 2]
Phase 2 clinical trial update on rasburicase for patients at high risk of tumor lysis syndrome during cycle 2; results posted after completi…
-
CLINICAL_TRIALS trial_result · 2020-01-22Clinical Trial Update: A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy [Phase 1, Phase 2]
Phase I/II study evaluating mis-matched immune cells (AlloStim) in patients with advanced hematological malignancies; trial completed.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H [Phase 1, Phase 2]
Phase 1/2 trial evaluating stem cell transplantation with CAMPATH 1H and less toxic chemotherapy for myelodysplastic disorders and leukemia;…
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide [Phase 2]
Phase 2 clinical trial update on mismatched transplantation using high-dose post-transplant cyclophosphamide completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Lirilumab and Nivolumab With 5-Azacitidine in Patients With Myelodysplastic Syndromes (MDS) [Phase 2]
Phase 2 trial investigating lirilumab and nivolumab with 5-azacitidine in myelodysplastic syndromes has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Eltrombopag With Decitabine in Advanced Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial of eltrombopag with decitabine in advanced myelodysplastic syndrome has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases [NA]
Clinical trial update for reduced intensity conditioning and haploidentical related bone marrow transplant in hematologic diseases; the stud…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults [Phase 2]
Phase 2 trial investigating an immunosuppressive regimen followed by blood cell transplant for treating blood cancers in older adults; compl…
-
CLINICAL_TRIALS trial_result · 2019-12-16Clinical Trial Update: Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances [Phase 2]
Phase 2 clinical trial update on stem cell transplantation with T-cell add-back for bone marrow malignancies, completed.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and Umbilical Cord Blood Transplantation for hematologic cancers complete…
-
CLINICAL_TRIALS trial_result · 2019-12-06Clinical Trial Update: Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever [Phase 4]
A Phase 4 clinical trial comparing cefepime to ceftazidime as empirical therapy for neutropenic fever has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: Doxercalciferol in Treating Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia [Phase 2]
A Phase 2 trial evaluating doxercalciferol in patients with myelodysplastic syndromes or related leukemias has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial evaluating chemotherapy and peripheral stem cell transplantation followed by immunotherapy in patients with leukemia …